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Abstract 
Objective: Postcraniotomy headache causes considerable pain and can be difficult 
to treat. We therefore tested the hypothesis that a single 100-mg preoperative dose 
of diclofenac reduces the intensity of postcraniotomy headache, and reduces 
analgesic requirements. 
Methods: 200 patients having elective craniotomies were randomly assigned to 
diclofenac (n=100) or control (n=100). Pain severity was assessed by an 
independent observer using a 10-cm-long visual analogue scale the evening of 
surgery, and on the 1st and 5th postoperative days. Analgesics given during the first 
five postoperative days were converted to intramuscular morphine equivalents. 
Results were compared using Mann-Whitney-tests; P<0.05 was considered 
statistically significant.       
Results: Baseline and surgical characteristics were comparable in the diclofenac and 
control groups. Visual analogue pain scores were slightly, but significantly lower with 
diclofenac at all times (means and 95% confidence intervals): the evening of surgery, 
2.47 (1.8-3.1) vs. 4. 37(5.0-3.7), (P<0.001); first postoperative day, 3.98 (3.4-4.6) vs. 
5.6 (4.9-6.2) cm (P<0.001) and 5th postoperative day: 2.8 (2.2-3.4) vs. 4.0 ± (3.3-
4.7) cm (P = 0.013). Diclofenac reduced systemic analgesic requirements over the 
initial five postoperative days (mean and 95% CI): 3.3 (2.6 -3.9) vs. 4.3 (3.5-5.1) mg 
morphine equivalents (p<0.05).  
Conclusions: Preoperative diclofenac administration reduces postcraniotomy 
headache and postoperative analgesic requirements — a benefit that persisted 
throughout five postoperative days.  
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Introduction 
According to the International Headache Society, acute postcraniotomy headache 
(PCH) is defined as a headache of variable intensity, being most serious at the site of 
surgical intervention and developing within 7 days after craniotomy. Typically, pain 
resolves within 3 months[1]. The headache is mainly nociceptive in nature and largely 
results from surgical damage to pericranial muscle and soft tissue [2],[3].  
De Benedittis first recognized that the incidence of PCH is as high as 60%, 
and that two-third of craniotomy patients report moderate to severe headaches[4]. 
Subsequent studies have shown that the incidence of PCH is underestimated both by 
physicians and nurses [5, 6],[7]. The past decade has seen publication of many 
studies assessing the efficacy and safety of preoperative, intraoperative, and 
postoperative treatments. Nonetheless, two recent systematic reviews concluded that 
“no firm recommendations on analgesia following craniotomy can be given” [8],[9].  
Most previous clinical studies assessed the effect of intraoperative and 
postoperative treatments, such as local infiltration of the surgical site before 
craniotomy and administration of different analgesics after craniotomies [8], [9] [10]. 
In contrast, there are limited data on the efficacy of preoperatively administered 
analgesics on the incidence and severity of postcraniotomy headache. As 
postcraniotomy headache is believed to be nociceptive in nature, it is conceivable 
that preoperative administration of non-steroidal anti-inflammatory agents decreases 
local inflammation and consequent sensitization and pain windup during craniotomy.  
We therefore tested the hypothesis that a single preoperative oral dose of diclofenac 
in adults reduces the severity of acute postcraniotomy headache, and decreases the 
need for opioid analgesia.  
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Patients and methods 
This study was conducted with approval from the University of Debrecen 
Medical Ethics Committee and the National Medical Ethics Committee (Registration 
number: 5481/2013/EKU, responsible person: József Szentmiklósi; Department of 
Pharmacology, University of Debrecen, 98. Nagyerdei krt. Debrecen, Hungary, 
Phone: +3652411600) and written consent from all patients. The study was 
registered in Clinical Trials.gov (Registration number: NCTO 1907984, Principal 
investigator: Csilla Molnár). We enrolled consecutive adults having elective 
craniotomies for brain tumors at the Department of Neurosurgery, University of 
Debrecen. Only patients who were alert preoperatively were included. Patients taking 
non-steroidal anti-inflammatory agents prior to surgery and with preoperative aphasia 
were excluded.   
Before starting the study, we evaluated postoperative pain in 54 craniotomy 
patients [11]. Pain was assessed using 10-cm-long visual analog scores (VAS) 
preoperatively, on the evening of surgery, the first postoperative morning, and on the 
fifth postoperative morning. Cumulative postoperative pain scores were computed, 
and averaged 14.3 ± 9.3 cm.  Based on an anticipated 20% decrease of the 
cumulative VAS score, we estimated that 182 patients would provide 90% power at 
alpha level of 0.05; we thus enrolled 200 patients to account for drop-outs and 
technical failures. The results of that pilot study were not included in the present 
analysis, none of the patients from the pilot study were included in the present study.  
Patients were assigned to diclofenac or no preventive treatment on the basis 
of sequentially numbered opaque envelopes, using a 1:1 computer-generated 
allocation without stratification. The envelopes were opened one hour before the 
anticipated start of surgery. Neither the physician performing the anesthesia, nor the 
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physicians obtaining postoperative VAS scores were aware of patient assignments; 
the study was thus entirely double-blinded.  
Patients were given 7.5 mg. midazolam p.o. one hour before anticipated 
induction of anesthesia. In those assigned to diclofenac, 100 mg of the drug was 
given orally along with midazolam. Others were given midazolam alone.  Patient 
selection and randomization is shown in Figure 1.  
Anesthesia was induced with propofol (1-2.5 mg/kg) and subsequently 
maintained with fentanyl, rocuronium, and sevoflurane. Fentanyl was given as an 
initial bolus of 100-150 µg, followed by an infusion of 2 µg/kg/h. No nitrous oxide was 
administered. At the end of the operation, the surgical site was infiltrated with a 
combination of 2% lidocaine and epinephrine. All patients were admitted to the 
neurosurgical ICU for postoperative observation.  
A stepwise analgesic regimen was used per protocol. Severity of pain was 
assessed regularly by the ICU nurses and additional analgesics were given when 
headache severity exceeded a VAS of 3 cm. Additional analgesics were given both  
in case of headache and in patients with infratentorial surgery in case of neck-
muscle-pain as well. 
The initial response was paracetamol (1-2 g given intravenously). If necessary, oral 
tramadol was added at a dose of 100 mg. Fentanyl was reserved for patients in 
whom VAS scores remained >3 cm after paracetamol and tramadol administration. 
Cumulative analgesics were transformed to equi-analgesic doses of intramuscular 
morphine according to the table of the Oxford Pain Site [12].  
Before surgery, patients were queried about preoperative headache, its 
severity, and any routine analgesic use; headaches lasting more than 3 months were 
considered chronic. Pain was assessed at rest in semi-sitting position with a 10-cm-
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long visual analogue scale. In addition to the nursing assessment that was used to 
guide analgesic management, an independent physician (who was unaware of 
randomization) asked patients to rate their worst daily pain. Only these physician 
assessments were used for statistical analysis.  
 Statistical analysis was performed using Statistica for Windows (Statsoft, 
Tulsa, USA) statistical program. A normality test revealed that VAS scores and 
analgesic requirements were not normally distributed; Mann-Whitney U tests were 
thus used for comparisons. Repeated-measure analysis of variance was used for 
multiple comparisons. Results are presented as means and 95% confidence 
intervals; P<0.05 was considered statistically significant.  
 
Results 
 
A total of 200 patients were enrolled. Baseline and surgical characteristics of 
the treatment groups were similar (Table 1).  
VAS scores were comparable preoperatively, but were significantly lower the 
evening after surgery and on the first and fifth postoperative days in patients 
randomized to diclofenac (Fig. 2). The distribution of postcraniotomy headache of 
different severity in the entire population showed, that in the diclofenac group more 
patients reported on “no pain” or “mild pain” throughout the study period except for 
the 5th postoperative day (Table 2).  
None of our patients required postoperative opioids. Doses of other analgesics 
were nonetheless converted to intramuscular morphine equivalents to facilitate 
comparison. The mean morphine equivalent analgesic doses necessary to maintain 
VAS scores ≤3 cm was lower in the diclofenac than control group: 3.3 (95% CI: 2.6-
3.9) vs. 4.3 (3.5-5.1) mg, p=0.044).   
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Figure 3 depicts the VAS scores observed after supratentorial surgical 
interventions. In this subgroup of patients, preventive diclofenac was predominantly 
effective in the early postoperative period, whereas on the 5th postoperative day it 
was no longer superior. In contrast, administration of diclofenac resulted in a more 
effective pain relief in patients who had infratentorial interventions and benefit was 
maintained in the late postoperative period (Fig. 4).  
No postoperative surgical bleeding, gastrointestinal complications, or kidney 
dysfunction was observed in any of our patients during the initial five postoperative 
days. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 8 
Discussion 
In patients undergoing elective craniotomy oral premedication with diclofenac 
100mg, given 1 hour before surgery, reduces postcraniotomy headache. In the 
largest case series, two-thirds of the patients reported moderate-to-severe headache 
after craniotomy [4]. A more recent study indicated that 55% of craniotomy patients 
report moderate-to-severe pain in the first 24 hours [13]. Our results are consistent 
with previous reports, with 52% of the diclofenac patients and 73% of the control 
patients reporting moderate-to-severe pain the day after surgery. Postcraniotomy 
headache was thus common, despite scalp infiltration with local anesthetic, which 
provides a distinct but transient benefit [3][14].    
Surgery causes tissue injury and inflammation that stimulates nociceptors. 
Nociception, in turn, provokes central sensitization, windup, and activation of brain 
structures involved in pain perception [9]. Reducing the initial nociceptive stimulus 
may thus reduce post-procedural pain which is the basis for preemptive analgesia, a 
concept introduced by Wall in the late 1980’s [15].   
Non-steroidal anti-inflammatory agents have proven to be effective for 
preemptive analgesia in various types of surgery [16]. Acute postcraniotomy 
headache appears to include components of site-of-injury and tension-type 
headaches [2],[9]. We found that preoperative administration of just a single dose of 
the non-steroidal inflammatory agent diclofenac slightly reduced both the incidence 
and the severity of acute postcraniotomy headache. Furthermore, the benefit 
persisted throughout five postoperative days which far exceeds the few hours over 
which the drug is normally analgesic. Effective preventive analgesia is thus the most 
likely explanation for our results.  
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Although there are reports on the usefulness of preemptive analgesia in 
animal models [17],[18] , its clinical efficacy remains debatable. Previous reviews of 
Moiniche [19]  and Dahl [20]  concluded that although in some studies it appeared to 
be effective, preemptive analgesia generally was not superior to postoperative pain 
relief in terms of reduced pain scores. More recently, Ong et al. conducted a meta-
analysis of 3,261 published cases and concluded that preemptive local anesthetic 
infiltration and systemic NSAID administration may improve analgesic consumption 
and time to first analgesic administration without influencing postoperative pain 
scores[21] . None of these reviews included neurosurgical studies.  
Infratentorial craniotomies are apparently more likely to provoke chronic 
postcraniotomy headaches than supratentorial procedures  [4],[3]. Interestingly, 
preventive treatment with diclofenac was more effective for infratentorial than 
supratentorial operations. Although a causal relationship has yet to be established, 
intense acute surgical pain is highly associated with chronic incisional pain [3]. 
Superior efficacy of diclofenac for infratentorial procedures thus appears fortuitous, 
and may help to reduce persistent incisional pain.  Unfortunately, we were unable to 
evaluate the incidence of chronic postcraniotomy headache and can thus only 
speculate about potential long-term benefit; an important limitation in the present 
study.  
The incidence of postcraniotomy hematoma is about 2%, with 88% of the 
bleeding occurring within 6 hours after surgery[22]. Non-steroidal anti-inflammatory 
drugs are often avoided in neurosurgery for fear of increasing bleeding risk [23] or 
started 6-24 hours postoperatively[24],[25]. No intracranial or gastrointestinal 
bleedings were detected in any of our 200 patients, but our study was not even 
vaguely powered for these rare (but serious) complications.   
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In summary, a single preoperative dose of diclofenac reduced the severity of 
acute postcraniotomy headache, and decreased analgesic requirements over a five-
day period in adults. These data suggest that preventive analgesia provides a small, 
but distinct benefit and might be considered in patients having craniotomies.  
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Figure legends: 
Figure 1. Patient selection and randomization 
Figure 2. Median VAS scores in patients randomized to diclofenac (open circles) or 
vs. no treatment (filled squares); error bars show 95% confidence intervals.  
Figure 3. Comparison of VAS scores of control (n=81) and diclofenac (n=84) groups 
in supratentorial interventions. Medians and 0.95 confidence intervals are presented.  
Figure 4. Comparison of VAS scores of control (n=19) and diclofenac (n=16) groups 
in infratentorial surgical interventions. Medians and 0.95 confidence intervals are 
presented.   
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Figure 4 
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Table 1. Baseline and surgical characteristics of the treatment groups   
 
  
Diclofenac (n=100) 
 
Control (n=100) 
Age (years) 55 ± 10 55 ± 10 
Gender (F/M) 56/44 49/51 
Type of intervention 
(supratentorial vs. 
infratentorial)  
 
84/16 
 
81/19 
Previous headache 
(Y/N) 
 
33/67 
 
40/60 
Chronic headache (n) 9 7 
Duration of surgery 
(min) 
 
209.7±55.9 
 
211.0±60.9 
Intraoperative fentanyl 
dose (µg/kgBW/h) 
 
2 ± 0.7 
 
2.5 ± 0.8 
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Table 2. Distribution of postcraniotomy headache according to severity. Number of 
cases are presented. P-value indicates differences between “no pain + mild pain” vs. 
“moderate+severe pain” cases in diclofenac and control groups 
 
  
0 
Mild 
(VAS 1-3) 
Moderate 
(VAS 4-6) 
Severe 
(VAS 7-10) 
 
p-value 
 
Evening of surgery 
 
 
Control 
 
29 
 
11 
 
28 
 
32 
 
 
<0.0001  
Diclofenac 
 
55 
 
14 
 
17 
 
14 
  
1st postoperative day 
 
Control 
 
12 
 
15 
 
29 
 
44 
 
 
= 0.003 
 
 
Diclofenac 
 
27 
 
21 
 
28 
 
24 
  
5th postoperative day 
 
Control 
 
39 
 
11 
 
20 
 
30 
 
 
= 0.11 
 
 
Diclofenac 
 
40 
 
22 
 
20 
 
18 
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Highlights 
 The incidence of postcraniotomy headache (PCH) has been reported between 
55- 60%.  
 The effect of preoperatively administered NSAID on the severity of PCH was 
tested.  
 Preoperative diclofenac decreases severity of PCH in the early postoperative 
period. 
 Post-operative analgesic requirements could also be decreased.  
